Procter & Gamble Hygiene and Health Care (BOM:500459) Cyclically Adjusted Revenue per Share: ₹1,306.71 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:500459 Procter & Gamble Hygiene and Health Care Ltd BOM:500459
64 GF Score
Price ₹8,318.45
GF Value ₹14,291.82
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Procter & Gamble Hygiene and Health Care Cyclically Adjusted Revenue per Share?

Procter & Gamble Hygiene and Health Care BOM:500459 -0.64% 64 Cyclically Adjusted Revenue per Share is ₹1,306.71 as of Jun. 2026. GuruFocus rates BOM:500459 with a GF Score™ of 64/100 and a GF Value™ of ₹14,291.82 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Procter & Gamble Hygiene and Health Care's adjusted revenue per share for the three months ended in Jun. 2026 was ₹274.159. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹1,306.71 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Procter & Gamble Hygiene and Health Care's average Cyclically Adjusted Revenue Growth Rate was 5.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Procter & Gamble Hygiene and Health Care was 10.00% per year. The lowest was 7.60% per year. And the median was 8.90% per year.

As of today (2026-08-19), Procter & Gamble Hygiene and Health Care's current stock price is ₹8318.45. Procter & Gamble Hygiene and Health Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹1,306.71. Procter & Gamble Hygiene and Health Care's Cyclically Adjusted PS Ratio of today is 6.37.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Procter & Gamble Hygiene and Health Care was 16.19. The lowest was 6.36. And the median was 13.24.


Procter & Gamble Hygiene and Health Care  (BOM:500459) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Procter & Gamble Hygiene and Health Care's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8318.45/1306.71
=6.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Procter & Gamble Hygiene and Health Care was 16.19. The lowest was 6.36. And the median was 13.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Procter & Gamble Hygiene and Health Care Cyclically Adjusted Revenue per Share Related Terms


Procter & Gamble Hygiene and Health Care Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Procter & Gamble Hygiene and Health Care's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Procter & Gamble Hygiene and Health Care Cyclically Adjusted Revenue per Share Chart

Procter & Gamble Hygiene and Health Care Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 932.77 1,037.37 1,122.29 1,190.07 1,288.90

Procter & Gamble Hygiene and Health Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,236.12 1,263.38 1,275.62 1,288.90 1,306.71

BOM:500459 vs PG, CL, KVUE: Cyclically Adjusted Revenue per Share Comparison

For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Procter & Gamble Hygiene and Health Care Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Procter & Gamble Hygiene and Health Care's Cyclically Adjusted PS Ratio falls into.


BOM:500459
64GF Score
Procter & Gamble Hygiene and Health Care Ltd BOM:500459
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Procter & Gamble Hygiene and Health Care Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Procter & Gamble Hygiene and Health Care's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=274.159/167.3573*167.3573
=274.159

Current CPI (Jun. 2026) = 167.3573.

Procter & Gamble Hygiene and Health Care Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 184.944 105.961 292.105
201612 198.158 105.196 315.251
201703 176.777 105.196 281.236
201706 154.906 107.109 242.041
201709 202.578 109.021 310.975
201712 216.925 109.404 331.834
201803 175.232 109.786 267.122
201806 161.575 111.317 242.918
201809 243.954 115.142 354.584
201812 252.040 115.142 366.337
201903 215.447 118.202 305.042
201906 195.098 120.880 270.112
201909 262.544 123.175 356.717
201912 264.741 126.235 350.982
202003 202.141 124.705 271.278
202006 194.388 127.000 256.159
202009 310.992 130.118 399.997
202012 313.752 130.889 401.169
202103 233.768 131.771 296.901
202106 241.985 134.084 302.034
202109 325.349 135.847 400.815
202112 336.186 138.161 407.230
202203 273.984 138.822 330.303
202206 232.787 142.347 273.687
202209 320.678 144.661 370.990
202212 349.395 145.763 401.157
202303 271.515 146.865 309.401
202306 261.465 150.280 291.177
202309 349.690 151.492 386.312
202312 348.375 152.924 381.255
202403 307.520 153.035 336.301
202406 285.697 155.789 306.912
202409 348.962 157.882 369.905
202412 383.910 158.323 405.817
202503 304.723 157.552 323.688
202506 288.105 159.755 301.815
202509 353.917 162.289 364.969
202512 388.142 163.281 397.832
202603 288.843 164.272 294.267
202606 274.159 167.357 274.159

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹1,306.71 mean?
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Cyclically Adjusted Revenue per Share of ₹1,306.71 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Procter & Gamble Hygiene and Health Care and its competitors.
Is Procter & Gamble Hygiene and Health Care's Cyclically Adjusted Revenue per Share too high?
Procter & Gamble Hygiene and Health Care's current Cyclically Adjusted Revenue per Share is ₹1,306.71. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Cyclically Adjusted Revenue per Share compare to PG and CL?
Procter & Gamble Hygiene and Health Care's Cyclically Adjusted Revenue per Share of ₹1,306.71 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Revenue per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. Procter & Gamble Hygiene and Health Care's current Cyclically Adjusted Revenue per Share is ₹1,306.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹14,291.82, compared to a current price of ₹8,318.45 — trading 41.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹1,306.71. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Cyclically Adjusted Revenue per Share is ₹1,306.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?

Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued. The current stock price of ₹8,318.45 is trading 41.8% below its estimated GF Value™ of ₹14,291.82. GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.

Key valuation signals for BOM:500459:

  • Cyclically Adjusted Revenue per Share: ₹1,306.71
  • GF Value™: ₹14,291.82 vs. price of ₹8,318.45 (41.8% below fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Procter & Gamble Hygiene and Health Care Business Description

Other Exchanges PGHH:India
Address Cardinal Gracias Road, P&G Plaza, Chakala, Andheri (East), Mumbai, MH, IND, 400099
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
64GF Score

Get the complete analysis for BOM:500459

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,318.45
Price
₹14,291.82
GF Value